$16.470
-0.879 (-5.34%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
IMNM Prediction & Forecast by Similar Chart Analysis
Alphio's IMNM stock price prediction model matches the current Immunome Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.30 (-1.05%). The 1-week path is $16.41 (-0.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Immunome Inc Stock?
Immunome Inc is currently a hold. The stock is trading at $16.47, down 15.75% over the last five days, with a very low RSI of 13.703 indicating it is oversold. However, the company has a strong cash position of $582.7 million, which can fund operations into 2028, and positive catalysts from FDA acceptance of its drug application. The main risk is the negative net income, which was -$73.1 million in Q2 2026, indicating ongoing financial challenges.
IMNM stock price ended at $16.47 on Friday, after losing -5.34%
Immunome Inc (IMNM) last closed at $16.47, losing -5.34%. These facts feed the 1-day and 1-week IMNM price prediction above.
Forecast Drivers
Immunome Inc (IMNM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches IMNM, ranked by similarity.
Seasonality analysis for IMNM
Historically the probability of a positive October return for IMNM is 84.48%. December offers the highest probability of a positive month at 88.37%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.